Thursday, March 1, 2018

FDA, DOJ Take Enforcement Action Against Defiant 503B ...

Inside Health Policy-2 hours ago
FDA announced Thursday (March 1) that it is working with the Department of Justice to block a registered 503B compounder from “manufacturing, processing, packing, labeling, holding and/or distributing” its product after the company disobeyed FDA's wishes and continued compounding after it had to recall all of its sterile ...
Post a Comment